Axitinib as a third or further line of treatment in renal cancer: a single institution experience

Kidney cancer is a lethal neoplasm that affects several thousands of people every year. Renal cell carcinoma (RCC) is the most common histologic type. Recent developments in the therapeutic approach include an...

Source: BMC Urology - June 2, 2020 Category: Urology & Nephrology Authors: G. Tsironis, M. Liontos, A. Kyriazoglou, K. Koutsoukos, A. Tsiara, M. Kaparelou, R. Zakopoulou, A. Cohen, E. Skafida, S. Fontara, F. Zagouri, A. Bamias and M. A. Dimopoulos Tags: Research article Source Type: research